Evidence map›Paper›PMID 29775474›Full record

ArticlePLoS pathogens2018

The Cryptococcus neoformans Titan cell is an inducible and regulated morphotype underlying pathogenesis.

Ivy M Dambuza, Thomas Drake, Ambre Chapuis, Xin Zhou, Joao Correia, Leanne Taylor-Smith, Nathalie LeGrave, Tim Rasmussen, Matthew C Fisher, Tihana Bicanic and 7 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 128 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
128citing papers in PubMed, 1 pooled it
14.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

128 citing papers in PubMed, 1 synthesis or guideline pooled it, 190 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Meiosis-specific genes play roles in ploidy reduction inProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Journal of medical microbiology · 2026
    Article
  16. Review
  17. The Vacuolar Protein 8 (Vac8) Homolog inJournal of fungi (Basel, Switzerland) · 2025
    Article
  18. Article
  19. Review
  20. Article

68 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Ivy M DambuzaMedical Research Council Centre for Medical Mycology at the University of Aberdeen, Aberdeen Fungal Group, Institute of Medical Sciences, Foresterhill, Aberdeen, United Kingdom.ORCID 0000-0001-6556-6476
Thomas DrakeMedical Research Council Centre for Medical Mycology at the University of Aberdeen, Aberdeen Fungal Group, Institute of Medical Sciences, Foresterhill, Aberdeen, United Kingdom.ORCID 0000-0002-3300-2577
Ambre ChapuisMedical Research Council Centre for Medical Mycology at the University of Aberdeen, Aberdeen Fungal Group, Institute of Medical Sciences, Foresterhill, Aberdeen, United Kingdom.
Xin ZhouInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, United Kingdom.
Joao CorreiaMedical Research Council Centre for Medical Mycology at the University of Aberdeen, Aberdeen Fungal Group, Institute of Medical Sciences, Foresterhill, Aberdeen, United Kingdom.ORCID 0000-0002-4376-978X
Leanne Taylor-SmithInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, United Kingdom.ORCID 0000-0001-6217-6499
Nathalie LeGraveMarine Biodiscovery Centre, Department of Chemistry, University of Aberdeen, Aberdeen, United Kingdom.ORCID 0000-0003-1172-4955
Tim RasmussenMarine Biodiscovery Centre, Department of Chemistry, University of Aberdeen, Aberdeen, United Kingdom.ORCID 0000-0003-1126-846X
Matthew C FisherDpt. Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.ORCID 0000-0002-1862-6402
Tihana BicanicInstitute of Infection and Immunity, St George's University of London, London, United Kingdom.
Thomas S HarrisonInstitute of Infection and Immunity, St George's University of London, London, United Kingdom.
Marcel JasparsMarine Biodiscovery Centre, Department of Chemistry, University of Aberdeen, Aberdeen, United Kingdom.ORCID 0000-0002-2426-6028
Robin C MayInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, United Kingdom.ORCID 0000-0001-5364-1838
Gordon D BrownMedical Research Council Centre for Medical Mycology at the University of Aberdeen, Aberdeen Fungal Group, Institute of Medical Sciences, Foresterhill, Aberdeen, United Kingdom.
Raif YuecelMedical Research Council Centre for Medical Mycology at the University of Aberdeen, Aberdeen Fungal Group, Institute of Medical Sciences, Foresterhill, Aberdeen, United Kingdom.
Donna M MacCallumMedical Research Council Centre for Medical Mycology at the University of Aberdeen, Aberdeen Fungal Group, Institute of Medical Sciences, Foresterhill, Aberdeen, United Kingdom.ORCID 0000-0003-4833-0378
Elizabeth R BallouMedical Research Council Centre for Medical Mycology at the University of Aberdeen, Aberdeen Fungal Group, Institute of Medical Sciences, Foresterhill, Aberdeen, United Kingdom.ORCID 0000-0001-8051-2302
University of Aberdeen · GBUniversity of Birmingham · GBSt George's, University of London · GBImperial College London · GB

Funding

Medical Research Council G0601171Medical Research Council MR/J008176/1Medical Research Council MR/R015600/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/N002482/1Wellcome Trust 102705/Z/13/Z
6 · The paper itself

Abstract

Fungal cells change shape in response to environmental stimuli, and these morphogenic transitions drive pathogenesis and niche adaptation. For example, dimorphic fungi switch between yeast and hyphae in response to changing temperature. The basidiomycete Cryptococcus neoformans undergoes an unusual morphogenetic transition in the host lung from haploid yeast to large, highly polyploid cells termed Titan cells. Titan cells influence fungal interaction with host cells, including through increased drug resistance, altered cell size, and altered Pathogen Associated Molecular Pattern exposure. Despite the important role these cells play in pathogenesis, understanding the environmental stimuli that drive the morphological transition, and the molecular mechanisms underlying their unique biology, has been hampered by the lack of a reproducible in vitro induction system. Here we demonstrate reproducible in vitro Titan cell induction in response to environmental stimuli consistent with the host lung. In vitro Titan cells exhibit all the properties of in vivo generated Titan cells, the current gold standard, including altered capsule, cell wall, size, high mother cell ploidy, and aneuploid progeny. We identify the bacterial peptidoglycan subunit Muramyl Dipeptide as a serum compound associated with shift in cell size and ploidy, and demonstrate the capacity of bronchial lavage fluid and bacterial co-culture to induce Titanisation. Additionally, we demonstrate the capacity of our assay to identify established (cAMP/PKA) and previously undescribed (USV101) regulators of Titanisation in vitro. Finally, we investigate the Titanisation capacity of clinical isolates and their impact on disease outcome. Together, these findings provide new insight into the environmental stimuli and molecular mechanisms underlying the yeast-to-Titan transition and establish an essential in vitro model for the future characterization of this important morphotype.

Indexed as

AnimalsCryptococcosisCryptococcus neoformansCyclic AMPDisease Models, AnimalFemaleFungal ProteinsHost-Pathogen InteractionsHumansHyphaeLungLung Diseases, FungalMaleMiceMice, Inbred BALB CMice, Inbred C57BLCyclic AMPFungal ProteinsTranscription Factors

Identifiers

PMID29775474
PMCPMC5959070
OpenAlexW2755163126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.